Expression of Glypican-3 (GPC3) in breast cancer tumors from Brazilian and Argentinean patients

被引：0
|
作者：
Lago Huvelle, Maria A. [1 ]
Maia, Aline [2 ]
Fujita, Andre [3 ]
Armanasco, Eduardo [4 ]
Bagnoli, Fabio [5 ]
de Oliveira, Vilmar Marques [5 ]
Longo Galvao Silva, Maria A. [5 ]
de Kier Joffe, Elisa Bal [1 ]
Sogayar, Mari C. [2 ]
Puricelli, Lydia [1 ]
Labriola, Leticia [2 ]
Peters, Maria G. [1 ]
机构：
[1] Inst Oncol Angel H Roffo, Res Area, Buenos Aires, DF, Argentina
[2] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil
[3] Univ Sao Paulo, Inst Matemat & Estat, Dept Ciencia Comp, Sao Paulo, Brazil
[4] Inst Oncol Angel H Roffo, Dept Surg, Buenos Aires, DF, Argentina
[5] Hosp Irmandade Snata Casa de Misericordia Sao Pau, Sao Paulo, Brazil
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-448
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
448
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Glypican-3 expression in malignant small round cell tumors
    Shibui, Yuichi
    Miyoshi, Kina
    Kohashi, Kenichi
    Kinoshita, Yoshiaki
    Kuda, Masaaki
    Yamamoto, Hidetaka
    Taguchi, Tomoaki
    Oda, Yoshinao
    ONCOLOGY LETTERS, 2019, 17 (03) : 3523 - 3528
  • [32] Establishment of high avidity CTL clones induced by HLA-A2 restricted glypican-3 (GPC3) peptide vaccine
    Yoshikawa, Toshiaki
    Suzuki, Shiro
    Nakatsugawa, Munehide
    Shirakawa, Hirofumi
    Nobuoka, Daisuke
    Sakemura, Noriko
    Motomura, Yutaka
    Nakatsura, Tetsuya
    CANCER RESEARCH, 2011, 71
  • [33] Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Glypican-3 (GPC3) antibody, as a serological and histological marker for hepatocellular carcinoma (vol 40, pg 477, 2010)
    Yasuda, E.
    Kumada, T.
    Toyoda, H.
    Kaneoka, Y.
    Maeda, A.
    Okuda, S.
    Yoshimi, N.
    Kozawa, O.
    HEPATOLOGY RESEARCH, 2011, 41 (01) : 101 - 101
  • [34] Expression of glypican-3 (GPC 3) and its significance as a novel marker of the degree of dedifferentiation in hepatocellular carcinoma
    Fukuzawa, Y
    Furuta, K
    Tagaya, T
    Sato, K
    Maeno, T
    Ayada, M
    Hotta, N
    Okumura, A
    Ishikawa, T
    Kakumu, S
    HEPATOLOGY, 2002, 36 (04) : 691A - 691A
  • [35] Role of Akt1 on the viability, migration and cytoskeleton organization of murine mammary tumor cells reexpresing glypican-3 (GPC3)
    Romero, Silvina A.
    Lago Huvelle, Maria A.
    Peluffo, Guillermo
    de Kier Joffe, Elisa Bal
    Giselle Peters, Maria
    CANCER RESEARCH, 2011, 71
  • [36] Glypican-3 (GPC3) modulates senescence, homotypic adhesion and migration of tumor mammary cells through the inhibition of the canonical Wnt pathway
    Lago Huvelle, Maria A.
    Buchanan, Cecilia
    Romero, Silvina A.
    de Kier Joffe, Elisa Bal
    Giselle Peters, Maria
    CANCER RESEARCH, 2011, 71
  • [37] Immunohistochemical Expression of Glypican-3 in Pediatric Tumors: An Analysis of 414 Cases
    Chan, Elaine S.
    Pawel, Bruce R.
    Corao, Diana A.
    Venneti, Sriram
    Russo, Pierre
    Santi, Mariarita
    Sullivan, Lisa M.
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2013, 16 (04) : 272 - 277
  • [38] Breast cancer: Relationship between GPC3 and EMT process
    Castillo, Lilian F.
    Novack, Gisela V.
    Joffe, Elisa Bal de Kier
    Peters, Maria G.
    CANCER RESEARCH, 2017, 77
  • [39] Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3
    Zhu, Xiao-ting
    Yuan, Ji-hang
    Zhu, Teng-teng
    Li, Yang-yang
    Cheng, Xiao-yang
    FEBS JOURNAL, 2016, 283 (20) : 3739 - 3754
  • [40] In vivo footprinting analysis of the Glypican 3 (GPC3) promoter region in neuroblastoma cells
    Boily, Gino
    Ouellet, Stephane
    Langlois, Sylvie
    Lariviere, Mathieu
    Drouin, Regen
    Sinnett, Daniel
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2007, 1769 (03): : 182 - 193
12345